| 1 | [SID56422465] | Active | IC50 | 0.05 | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | IC50 | 0.05 [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID56422465] | Active | Potency | 0.206 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 0.206 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 3 | [SID56422465] | Active | Potency | 0.206 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 0.206 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 4 | [SID56422465] | Active | Potency | 0.206 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 0.206 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 5 | [SID56422465] | Active | Potency | 0.206 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 0.206 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 6 | [SID56422465] | Active | IC50 | 0.69 | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay [AID489041, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | IC50 | 0.69 [uM] | | BioAssay | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay | | AID | 489041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID56422465] | Active | AC50 | 0.707 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | AC50 | 0.707 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID50111021] | Active | Potency | 0.8196 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 50111021 | | CID | 11957513 | | Outcome | Active | | Potency | 0.8196 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 9 | [SID56422465] | Active | Potency | 1 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 10 | [SID56422465] | Active | Potency | 1 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 11 | [SID56422465] | Active | AC50 | 1.284 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | AC50 | 1.284 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID56422465] | Active | Potency | 1.2995 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56422465] | Active | Potency | 1.7783 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 14 | [SID56422465] | Active | AbsAC35_uM | 1.97 | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_Dose_CherryPick_Activity [AID686920, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | AbsAC35_uM | 1.97 [uM] | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_Dose_CherryPick_Activity | | AID | 686920 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56422465] | Active | CC50 | 4.84 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | CC50 | 4.84 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID56422465] | Active | Potency | 5.1735 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 17 | [SID56422465] | Active | Potency | 5.1735 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 18 | [SID56422465] | Active | Potency | 5.1735 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 19 | [SID56422465] | Active | IC50 | 12.2 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | IC50 | 12.2 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID56422465] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID56422465] | Active | | | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435003, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435003 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID56422465] | Active | | | Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435020, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435020 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID56422465] | Active | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID56422465] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651611, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651611 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID56422465] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 26 | [SID56422465] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 27 | [SID56422465] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 28 | [SID56422465] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID56422465] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 30 | [SID56422465] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 31 | [SID56422465] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 32 | [SID56422465] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 33 | [SID56422465] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 34 | [SID56422465] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 35 | [SID56422465] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 36 | [SID56422465] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 37 | [SID56422465] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 38 | [SID56422465] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 39 | [SID56422465] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 40 | [SID56422465] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 41 | [SID56422465] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 42 | [SID56422465] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 43 | [SID56422465] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 44 | [SID56422465] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 45 | [SID56422465] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 46 | [SID56422465] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 47 | [SID56422465] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 48 | [SID56422465] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 49 | [SID56422465] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 50 | [SID56422465] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56422465 | | CID | 11957513 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|